05/05/2021
4:16 PM | TRACON Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/23/2021
3:24 PM | TRACON Pharmaceuticals (Filer)
| Form DEFA14A
| |
04/23/2021
3:12 PM | TRACON Pharmaceuticals (Filer)
| Form DEF 14A
| |
03/15/2021
3:37 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/10/2021
8:40 PM | New Enterprise Associates 14, L.P. (Filed by)
TRACON Pharmaceuticals (Subject)
| Form SC 13D/A
| |
03/09/2021
5:00 AM | Brown Scott B. (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2021
3:50 PM | Johnson-Pratt Lisa (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2021
3:48 PM | Johnson-Pratt Lisa (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/08/2021
7:14 AM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2021
4:26 PM | TRACON Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
|
02/25/2021
4:20 PM | TRACON Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/25/2021
3:11 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2021
2:09 PM | 683 Capital Management, LLC (Filed by)
TRACON Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/16/2021
7:33 AM | Ikarian Capital, LLC (Filed by)
TRACON Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/12/2021
4:20 PM | Opaleye Management Inc. (Filed by)
TRACON Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/09/2021
2:17 PM | Linden Capital L.P. (Filed by)
TRACON Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/02/2021
3:39 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2021
5:00 AM | THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
7:12 AM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/30/2020
5:24 PM | Chart Westcott Living Trust (Reporting)
Ikarian Capital, LLC (Reporting)
Ikarian Healthcare Fund GP, L.P. (Reporting)
Ikarian Healthcare Master Fund, L.P. (Reporting)
Shahrestani Neil (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2020
5:00 AM | TRACON Pharmaceuticals (Issuer)
WIGGINS MARK C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2020
5:00 AM | THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2020
7:21 AM | TRACON Pharmaceuticals (Filer)
| Form 424B5
| |
12/29/2020
7:11 AM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2020
8:53 AM | Opaleye Management Inc. (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2020
7:22 AM | TRACON Pharmaceuticals (Filer)
| Form 424B5
| |
12/22/2020
7:16 AM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2020
4:15 PM | TRACON Pharmaceuticals (Filer)
| Form 424B5
| |
12/09/2020
4:11 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2020
5:18 PM | Chart Westcott Living Trust (Reporting)
Ikarian Capital, LLC (Reporting)
Ikarian Healthcare Fund GP, L.P. (Reporting)
Ikarian Healthcare Master Fund, L.P. (Reporting)
Shahrestani Neil (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/10/2020
4:02 PM | TRACON Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/30/2020
3:19 PM | TRACON Pharmaceuticals (Filer)
| Form DEF 14A
| |
10/23/2020
8:30 PM | Opaleye Management Inc. (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2020
5:00 AM | THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/20/2020
3:14 PM | TRACON Pharmaceuticals (Filer)
| Form PRE 14A
| |
09/25/2020
8:30 PM | Opaleye Management Inc. (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2020
5:00 AM | THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/21/2020
7:30 AM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2020
8:22 PM | Chart Westcott Living Trust (Reporting)
Ikarian Capital, LLC (Reporting)
Ikarian Healthcare Fund GP, L.P. (Reporting)
Ikarian Healthcare Master Fund, L.P. (Reporting)
Shahrestani Neil (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4/A
| |
09/17/2020
8:19 PM | Chart Westcott Living Trust (Reporting)
Ikarian Healthcare Fund GP, L.P. (Reporting)
Ikarian Healthcare Master Fund, L.P. (Reporting)
Shahrestani Neil (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/16/2020
3:32 PM | TRACON Pharmaceuticals (Filer)
| Form 424B3
| |
09/15/2020
8:19 PM | Ikarian Capital, LLC (Reporting)
Ikarian Healthcare Master Fund, L.P. (Reporting)
Shahrestani Neil (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2020
5:49 PM | Ikarian Capital, LLC (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/14/2020
4:00 PM | Ikarian Capital, LLC (Filed by)
TRACON Pharmaceuticals (Subject)
| Form SC 13G
| |
09/14/2020
12:49 PM | TRACON Pharmaceuticals (Issuer)
WIGGINS MARK C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2020
11:15 PM | TRACON Pharmaceuticals (Filer)
| Form EFFECT
| |
09/09/2020
5:15 PM | Opaleye Management Inc. (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2020
5:00 AM | THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2020
8:24 PM | TRACON Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/03/2020
4:15 PM | Opaleye Management Inc. (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/31/2020
8:40 PM | Opaleye Management Inc. (Filed by)
TRACON Pharmaceuticals (Subject)
| Form SC 13G
| |
08/31/2020
8:36 PM | Opaleye Management Inc. (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/31/2020
8:33 PM | Opaleye Management Inc. (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/31/2020
7:13 AM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2020
7:18 AM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/25/2020
5:00 AM | THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2020
5:06 AM | THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2020
7:28 PM | THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2020
7:17 PM | THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2020
4:23 PM | TRACON Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/03/2020
1:30 PM | TRACON Pharmaceuticals (Filer)
| Form CT ORDER
| |
07/09/2020
11:16 PM | TRACON Pharmaceuticals (Filer)
| Form EFFECT
| |
06/25/2020
4:46 PM | THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2020
4:32 PM | LARUE WILLIAM R (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2020
4:31 PM | MATTINGLY MARTIN A (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2020
4:30 PM | TRACON Pharmaceuticals (Issuer)
Twiford J Rainer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2020
4:29 PM | TRACON Pharmaceuticals (Issuer)
WORLAND STEPHEN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2020
4:27 PM | TRACON Pharmaceuticals (Issuer)
Walker Paul Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2020
4:24 PM | PELLETIER SAUNDRA L (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2020
7:40 AM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2020
4:21 PM | TRACON Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2020
3:44 PM | TRACON Pharmaceuticals (Filer)
| Form DEFA14A
| |
04/24/2020
7:30 AM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/14/2020
4:16 PM | TRACON Pharmaceuticals (Filer)
| Form PRE 14A
| |
03/19/2020
7:30 AM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2020
5:21 PM | THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2020
5:02 PM | THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2020
3:13 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/10/2020
7:15 AM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2020
3:12 PM | Brown Scott B. (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2020
3:11 PM | TRACON Pharmaceuticals (Issuer)
WIGGINS MARK C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2020
3:10 PM | THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
3:10 PM | TRACON Pharmaceuticals (Issuer)
WIGGINS MARK C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
3:09 PM | Brown Scott B. (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
3:08 PM | THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2020
3:01 PM | Linden Capital L.P. (Filed by)
TRACON Pharmaceuticals (Subject)
| Form SC 13G/A
| |
01/13/2020
7:20 AM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2020
7:01 AM | TRACON Pharmaceuticals (Filer)
| Form 424B5
| |
12/20/2019
6:14 AM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2019
9:47 AM | Puissance Capital Fund LLC (0001695347) (Reporting)
Puissance Capital Management LP (Reporting)
Puissance Cross-Border Opportunities IV LLC (Reporting)
Puissance Cross-Border Opportunities V LLC (Reporting)
TRACON Pharmaceuticals (Issuer)
Wang Theodore T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2019
3:52 PM | TRACON Pharmaceuticals (Filer)
| Form 424B3
| |
11/25/2019
3:18 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/24/2019
11:15 PM | TRACON Pharmaceuticals (Filer)
| Form EFFECT
| |
11/12/2019
3:43 PM | TRACON Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
11/06/2019
4:08 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2019
3:18 PM | TRACON Pharmaceuticals (Filer)
| Form DEF 14A
| |
10/21/2019
7:20 AM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2019
4:02 PM | TRACON Pharmaceuticals (Filer)
| Form PRE 14A
| |
10/08/2019
11:15 PM | TRACON Pharmaceuticals (Filer)
| Form EFFECT
| |
10/03/2019
3:34 PM | TRACON Pharmaceuticals (Filer)
| Form S-3/A
| |
